FDA.reportPublic FDA data

Beyfortus 50 MG per 0.5 ML Prefilled Syringe

RxCUI
2642412
RxNorm name
Beyfortus 50 MG per 0.5 ML Prefilled Syringe
Display name
Beyfortus 50 MG per 0.5 ML Prefilled Syringe
Full name
Beyfortus 50 MG per 0.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761328Beyfortusnirsevimab-alip351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BEYFORTUSNIRSEVIMABSanofi Vaccines US Inc.2f08fa60-f674-432d-801b-1f9514bd9b392026-06-26Warnings, Adverse reactionsExact identifier
rxcui: 2642412

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2f08fa60-f674-432d-801b-1f9514bd9b39Beyfortus 50 MG per 0.5 ML Prefilled SyringeSY26These highlights do not include all the information needed to use BEYFORTUS ® safely and effectively. See full prescribing information for BEYFORTUS. BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 202320260428
2f08fa60-f674-432d-801b-1f9514bd9b390.5 ML nirsevimab-alip 100 MG/ML Prefilled Syringe [Beyfortus]SBD26These highlights do not include all the information needed to use BEYFORTUS ® safely and effectively. See full prescribing information for BEYFORTUS. BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 202320260428
2f08fa60-f674-432d-801b-1f9514bd9b39Beyfortus 50 MG in 0.5 ML Prefilled SyringePSN26These highlights do not include all the information needed to use BEYFORTUS ® safely and effectively. See full prescribing information for BEYFORTUS. BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 202320260428
2f08fa60-f674-432d-801b-1f9514bd9b390.5 ML Beyfortus 100 MG/ML Prefilled SyringeSY26These highlights do not include all the information needed to use BEYFORTUS ® safely and effectively. See full prescribing information for BEYFORTUS. BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 202320260428